These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10188630)

  • 21. Enhanced striatal dopamine D(2) receptor-induced [35S]GTPgammaS binding after haloperidol treatment.
    Geurts M; Hermans E; Maloteaux JM
    Eur J Pharmacol; 1999 Oct; 382(2):119-27. PubMed ID: 10528146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of a strong influence of neuroleptic decanoates on dopaminergic and GABAergic functions.
    Ossowska K; Wolfarth S
    Pol J Pharmacol; 1995; 47(2):99-107. PubMed ID: 8688897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of apomorphine administration on rearing activity of control and experimental rats withdrawn from long-term haloperidol treatment.
    Bernardi MM; Palermo-Neto J
    Gen Pharmacol; 1984; 15(4):363-5. PubMed ID: 6541605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute buspirone abolishes the expression of behavioral dopaminergic supersensitivity in mice.
    Queiroz CM; Alcântara FB; Yagüe AM; Bibancos T; Frussa-Filho R
    Braz J Med Biol Res; 2002 Feb; 35(2):237-42. PubMed ID: 11847528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monosialoganglioside cotreatment prevents haloperidol treatment-associated loss of cholinergic enzymes in rat brain.
    Mahadik SP; Mukherjee S
    Biol Psychiatry; 1995 Aug; 38(4):246-54. PubMed ID: 8547447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracerebroventricular administration of cholecystokinin reduces stereotypy in dopamine-supersensitive rats.
    Tieppo CA; Silva AM; Palermo-Neto J; Nasello AG; Felicio LF
    Braz J Med Biol Res; 1995 Mar; 28(3):351-4. PubMed ID: 8520531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensitivity of dopamine D2 receptors following long-term treatment with roxindole.
    Seyfried CA; Bartoszyk GD
    Eur J Pharmacol; 1994 May; 257(1-2):67-72. PubMed ID: 7915991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
    Obuchowicz E; Krysiak R; Wieronska JM; Smialowska M; Herman ZS
    Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of long-term haloperidol treatment on striatal neuropeptides: relation to stereotyped behavior.
    Marin C; Engber TM; Bonastre M; Chase TN; Tolosa E
    Brain Res; 1996 Aug; 731(1-2):57-62. PubMed ID: 8883854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
    Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R
    Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms for metoclopramide-mediated sensitization and haloperidol-induced catalepsy in rats.
    Agovic MS; Yablonsky-Alter E; Lidsky TI; Banerjee SP
    Eur J Pharmacol; 2008 Jun; 587(1-3):181-6. PubMed ID: 18457824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The σ1 receptor regulates accumulation of GM1 ganglioside-enriched autophagosomes in astrocytes.
    Kasahara R; Yamamoto N; Suzuki K; Sobue K
    Neuroscience; 2017 Jan; 340():176-187. PubMed ID: 27815022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subchronic administration of clozapine, but not haloperidol or metoclopramide, decreases dopamine D2 receptor messenger RNA levels in the nucleus accumbens and caudate-putamen in rats.
    See RE; Lynch AM; Sorg BA
    Neuroscience; 1996 May; 72(1):99-104. PubMed ID: 8730709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Further dopaminergic supersensitivity to dopamine agonists by subchronic administration of haloperidol in rats treated with colchicine.
    Kamata K; Okuyama S; Hashimoto S; Aihara H; Kasuya Y
    Jpn J Pharmacol; 1986 Oct; 42(2):329-32. PubMed ID: 3795627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of GM1 ganglioside treatment on pre- and postsynaptic dopaminergic markers in the striatum of parkinsonian monkeys.
    Pope-Coleman A; Tinker JP; Schneider JS
    Synapse; 2000 May; 36(2):120-8. PubMed ID: 10767059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapidly induced dopaminergic supersensitivity: D1/D2 receptor participation and its prevention by an MAO-inhibitor.
    Kleinman A; Tieppo CA; Florez GM; Felicio LF; Nasello AG
    Pharmacol Biochem Behav; 2006 Nov; 85(3):592-600. PubMed ID: 17157367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional brain changes in [3H]SCH 23390 binding to dopamine D1, receptors after long-term haloperidol treatment: lack of correspondence with the development of vacuous chewing movements.
    Sasaki T; Kennedy JL; Nobrega JN
    Behav Brain Res; 1998 Feb; 90(2):125-32. PubMed ID: 9521545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disruption of dopamine D1/D2 receptor complex is involved in the function of haloperidol in cardiac H9c2 cells.
    Lencesova L; Szadvari I; Babula P; Kubickova J; Chovancova B; Lopusna K; Rezuchova I; Novakova Z; Krizanova O; Novakova M
    Life Sci; 2017 Dec; 191():186-194. PubMed ID: 29054453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of serotonergic agents on the up-regulation of dopamine D2 receptors induced by haloperidol in rat striatum.
    Ishikane T; Kusumi I; Matsubara R; Matsubara S; Koyama T
    Eur J Pharmacol; 1997 Feb; 321(2):163-9. PubMed ID: 9063684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double dissociation of the effects of haloperidol and the dopamine D3 receptor antagonist ABT-127 on acquisition vs. expression of cocaine-conditioned activity in rats.
    Banasikowski TJ; Bespalov A; Drescher K; Behl B; Unger L; Haupt A; Schoemaker H; Sullivan JP; Gross G; Beninger RJ
    J Pharmacol Exp Ther; 2010 Nov; 335(2):506-15. PubMed ID: 20724485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.